Compile Data Set for Download or QSAR
maximum 50k data
Found 35 Enz. Inhib. hit(s) with all data for assayid = 2 entry = 9618
TargetTyrosine-protein kinase Tec(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484221((S)-1-(2-(1-(4-(2,3- difluorophenoxy)phenyl)imidaz...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM480004((R)-1-(3-(1-(4-(2-fluoro-3-methoxyphenoxy)phenyl)i...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Tec(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484228((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM589232((S)-1-(2-(1-(4-(2-Fluoro-3-methoxyphenoxy)phenyl)-...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Tec(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM589232((S)-1-(2-(1-(4-(2-Fluoro-3-methoxyphenoxy)phenyl)-...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Tec(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484217((S)-1-(2-(1-(4-(3- methoxyphenoxy)phenyl)imidazo[1...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484228((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Tec(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484231((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Tec(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM480004((R)-1-(3-(1-(4-(2-fluoro-3-methoxyphenoxy)phenyl)i...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Tec(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484337((S)-1-(2-(1-(4-((2,6- difluorobenzyl)oxy) phenyl)i...)
Affinity DataIC50:  550nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484221((S)-1-(2-(1-(4-(2,3- difluorophenoxy)phenyl)imidaz...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484221((S)-1-(2-(1-(4-(2,3- difluorophenoxy)phenyl)imidaz...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM480004((R)-1-(3-(1-(4-(2-fluoro-3-methoxyphenoxy)phenyl)i...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484231((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484337((S)-1-(2-(1-(4-((2,6- difluorobenzyl)oxy) phenyl)i...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484228((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484217((S)-1-(2-(1-(4-(3- methoxyphenoxy)phenyl)imidazo[1...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484217((S)-1-(2-(1-(4-(3- methoxyphenoxy)phenyl)imidazo[1...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484337((S)-1-(2-(1-(4-((2,6- difluorobenzyl)oxy) phenyl)i...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484231((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50:  5.50E+3nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM589232((S)-1-(2-(1-(4-(2-Fluoro-3-methoxyphenoxy)phenyl)-...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484337((S)-1-(2-(1-(4-((2,6- difluorobenzyl)oxy) phenyl)i...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484337((S)-1-(2-(1-(4-((2,6- difluorobenzyl)oxy) phenyl)i...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484231((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484231((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484228((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484228((S)-1-(2-(1-(4-(2-fluoro-3- methoxyphenoxy)phenyl)...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484221((S)-1-(2-(1-(4-(2,3- difluorophenoxy)phenyl)imidaz...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484221((S)-1-(2-(1-(4-(2,3- difluorophenoxy)phenyl)imidaz...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484217((S)-1-(2-(1-(4-(3- methoxyphenoxy)phenyl)imidazo[1...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM484217((S)-1-(2-(1-(4-(3- methoxyphenoxy)phenyl)imidazo[1...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase ITK/TSK(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM589232((S)-1-(2-(1-(4-(2-Fluoro-3-methoxyphenoxy)phenyl)-...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM589232((S)-1-(2-(1-(4-(2-Fluoro-3-methoxyphenoxy)phenyl)-...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM480004((R)-1-(3-(1-(4-(2-fluoro-3-methoxyphenoxy)phenyl)i...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Suzhou Baijibugong Pharmaceutical Technology

US Patent
LigandPNGBDBM480004((R)-1-(3-(1-(4-(2-fluoro-3-methoxyphenoxy)phenyl)i...)
Affinity DataIC50: >1.00E+4nMAssay Description:The following Table shows the activity of selected compounds of this invention in the BTK, TEC, BLK, LYN, LCK inhibition assay. More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticleUS Patent